COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Affiliations

• ¹ Department of Immunology and Inflammation, Imperial College London, London, UK.
• ² Department of Infectious Disease, Imperial College London, London, UK.
• ³ Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
• ⁴ Imperial College NHS Healthcare Trust, London, UK.
• ⁵ Department of Infectious Disease, Imperial College London, London, UK. r.boyton@imperial.ac.uk.
• ⁶ Lung Division, Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK. r.boyton@imperial.ac.uk.